Core Viewpoint - Zhonghong Medical's stock price has declined, closing at 14.92 yuan with a drop of 3.24%, indicating a current state of underperformance since its IPO [1] Group 1: IPO and Initial Performance - Zhonghong Medical was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on April 27, 2021, with an initial public offering of 41.67 million shares at a price of 48.59 yuan per share [1] - The stock reached a peak price of 159.80 yuan on its first trading day, marking the highest price since its listing [1] - Currently, the stock is in a state of decline, having fallen below its initial offering price [1] Group 2: Fundraising and Financials - The total amount raised from the IPO was 2.025 billion yuan, with a net amount of 1.896 billion yuan after expenses, exceeding the originally planned fundraising by 1.317 billion yuan [1] - The initial fundraising plan aimed to raise 580 million yuan for projects related to nitrile gloves and working capital [1] - The total issuance costs for the IPO were 128 million yuan, with underwriting fees accounting for 107 million yuan [1] Group 3: Dividend Distribution - In 2022, Zhonghong Medical announced a profit distribution plan, distributing 7.00 yuan in cash per 10 shares and increasing the total share capital by 9 million shares through capital reserve [2] - For 2021, the company distributed 30.00 yuan in cash per 10 shares and increased the total share capital by 13.33 million shares [2] - The 2024 profit distribution plan includes a cash dividend of 2.5 yuan per 10 shares and a capital reserve increase of 3.88 million shares, resulting in a total share capital of approximately 428.86 million shares [3]

Core Points - Zhonghong Medical (300981.SZ) closed at 14.21 yuan, with a decline of 2.07%, and a total market capitalization of 6.094 billion yuan, currently in a state of breaking issue [1] - The company was listed on the Shenzhen Stock Exchange's ChiNext board on April 27, 2021, with an initial public offering of 41.67 million shares at a price of 48.59 yuan per share [1] - The highest price recorded on the first day of trading was 159.80 yuan, marking the peak since its listing, followed by a downward trend in stock price [1] - The total funds raised from the IPO amounted to 2.025 billion yuan, with a net amount of 1.896 billion yuan, exceeding the originally planned fundraising by 1.317 billion yuan [1] - The initial fundraising plan was to raise 580 million yuan for the production of nitrile gloves and to supplement working capital [1] Financial Distribution - The total issuance costs for the IPO were 128 million yuan, with underwriting and sponsorship fees amounting to 107 million yuan [2] - For the 2022 fiscal year, the profit distribution plan included a cash dividend of 7.00 yuan per 10 shares (tax included) and a capital reserve transfer of 3 shares for every 10 shares, resulting in a total cash dividend of 210,004,200 yuan [2] - The total share capital increased by 90,001,800 shares following the 2022 distribution [2] - For the 2021 fiscal year, the profit distribution plan included a cash dividend of 30.00 yuan per 10 shares (tax included) and a capital reserve transfer of 8 shares for every 10 shares, leading to a total cash dividend of 500,010,000 yuan [2] - The total share capital increased by 133,336,000 shares after the 2021 distribution [2] Future Projections - The 2024 profit distribution plan, announced for June 20, 2025, proposes a cash dividend of 2.5 yuan per 10 shares (tax included) and a capital reserve transfer of 1 share for every 10 shares, totaling a cash dividend of 97,142,899.50 yuan [3] - The total share capital is projected to increase to 428,864,960 shares after the 2024 distribution [3]

Core Viewpoint - Zhonghong Medical (300981.SZ) is currently experiencing a decline in stock price, closing at 14.59 yuan with a drop of 3.63%, indicating a state of breaking down since its IPO in April 2021 [1] Group 1: IPO and Initial Performance - Zhonghong Medical was listed on the Shenzhen Stock Exchange's ChiNext on April 27, 2021, with an initial public offering of 41.67 million shares at a price of 48.59 yuan per share [1][2] - On its first trading day, the stock reached a peak price of 159.80 yuan, marking the highest price since its listing, but has since experienced a downward trend [2] - The total funds raised from the IPO amounted to 2.025 billion yuan, with a net amount of 1.896 billion yuan, exceeding the originally planned fundraising by 1.317 billion yuan [2] Group 2: Use of Proceeds and Financial Performance - The initial plan for the raised funds was 580 million yuan, allocated for the nitrile glove project at Jiangxi Zhonghong Pulin Medical Products Co., Ltd. and for supplementing working capital [2] - The total issuance costs for the IPO were 128 million yuan, with underwriting and sponsorship fees accounting for 107 million yuan [3] Group 3: Dividend Distribution - In 2022, the company announced a profit distribution plan, distributing 7.00 yuan in cash per 10 shares (including tax) and increasing the total share capital by 9 million shares through capital reserve [3] - For the 2021 fiscal year, the company distributed 30.00 yuan in cash per 10 shares (including tax) and increased the total share capital by 13.33 million shares [3] - A future dividend plan for June 10, 2025, includes a distribution of 2.5 yuan in cash per 10 shares (pre-tax) and a share increase of 1 share for every 10 shares held [4]